NCT07164430View on ClinicalTrials.gov

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Not yet recruitingOBSERVATIONAL
Enrollment

2,100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Trial Locations (1)

2605

The Canberra Hospital, Garran

All Listed Sponsors
lead

Nicola Irwin

OTHER

NCT07164430 - The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory | Biotech Hunter | Biotech Hunter